Atlas Trials

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Clinical trial NCT02754830 · COMPLETED

Trial details

NCT number
NCT02754830
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2016-04-25
Primary completion
2018-07-10
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.